Interview with Derek Williams, Vice President and General Manager, Vifor Pharma…
You joined Vifor Pharma to establish a new structure in the UK. It is quite difficult to set up a new enterprise—what have been the main challenges for yourself and…
Address: Flughofstrasse 61, CH-8152 Glattbrugg,Germany
Tel: +41 58 851 80 00
Web: http://www.viforpharma.com/en/
Vifor Pharma is a fully integrated specialty pharma company within the Galenica Group. It unites all companies in the Pharma business sector of Galenica under one single umbrella organisation that researches, develops, produces and markets specific pharmaceutical products throughout the world.It is based on two main pillars: the business units Rx (prescription products) and Consumer Healthcare (OTC products). The operational basis of Vifor Pharma are lean and agile organisational structures. Vifor Pharma enjoys an increasing global presence. While the manufacture of all products is located in Switzerland and in the UK, the commercialisation is taken over by a wide network of affiliates and distributors all over the world.The business unit Vifor Pharma Consumer Healthcare manufactures and markets non-prescription products (OTC products) developed within Vifor Pharma or produced or sold under licence. Vifor Pharma plays a leading role in the area of non-prescription medicines, both in Switzerland and in selected countries of export. The focus of Vifor Pharma Consumer Health is on the development of own structures in key markets in Europe and on the continual optimisation of the product range through own developments and through the acquisition of products, licences and companies.
You joined Vifor Pharma to establish a new structure in the UK. It is quite difficult to set up a new enterprise—what have been the main challenges for yourself and…
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness to make bold bets on areas including consumer healthcare, medical cannabis, and research into…
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant Pfizer on a COVID-19 vaccine. The company, founded by Professor Ugur Sahin in…
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to unpack her important role within the global group and how Merck has pivoted to…
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number of headline-grabbing investments in sites in its home market of Germany and…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to innovative medicines and COVID-19 treatments. …
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big new investments from Merck and Bayer, the implications of the country’s new Digital…
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to…
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up until 2025. The aim of Merck’s proposed investment is to secure…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout the market for its long-term vision. How would you compare this…
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this extremely competitive and challenging global…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with Germany at the center of this process on the European continent. An example…
Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the increased prevalence of the disease in countries…
See our Cookie Privacy Policy Here
